PA
Perceptive Advisors Portfolio holdings
AUM
$2.67B
This Quarter Return
+29.47%
1 Year Return
+73.17%
3 Year Return
+837.18%
5 Year Return
+928.4%
10 Year Return
+11,818.46%
AUM
$1.12B
AUM Growth
+$1.12B
(+22%)
Cap. Flow
+$76.8M
Cap. Flow
% of AUM
6.87%
Top 10 Holdings %
Top 10 Hldgs %
44.03%
Holding
175
New
50
Increased
49
Reduced
22
Closed
29
Top Buys
| 1 |
BLCM
Bellicum Pharmaceuticals, Inc.
BLCM
|
$24.1M |
| 2 |
BLUE
bluebird bio
BLUE
|
$20.6M |
| 3 |
ANI Pharmaceuticals
ANIP
|
$17.6M |
| 4 |
Amicus Therapeutics
FOLD
|
$17.5M |
| 5 |
RLYP
RELYPSA INC COM
RLYP
|
$14.7M |
Top Sells
| 1 |
CELG
Celgene Corp
CELG
|
$25.8M |
| 2 |
Neurocrine Biosciences
NBIX
|
$22.3M |
| 3 |
Arrowhead Research
ARWR
|
$18.4M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
$15.5M |
| 5 |
DYAX
DYAX CORPORATION
DYAX
|
$13.8M |
Sector Composition
| 1 | Healthcare | 84.54% |
| 2 | Financials | 0.1% |
| 3 | Energy | 0.03% |
